Will this win help raise the profile of your work?
Winning such a prestigious and high-profile award has significantly raised the visibility of my work. Since the announcement, it has attracted widespread media coverage in Taiwan, helping more consumers and industry peers understand that our innovations have gained international recognition.
Globally, it has also opened doors to new commercial collaborations and press invitations, allowing us to expand the reach and impact of our psychobiotics.
You also serve on the board of the Taipei Women’s Rescue Foundation…
The Foundation supports survivors of domestic violence and digital sexual abuse, and advocates for gender justice in law and policy.
As a board member, I help guide strategic outreach and promote psychological recovery and empowerment, especially for women facing systemic trauma. Recently, we’ve been working to enhance national resilience planning, ensuring marginalised communities are not left behind in times of crisis.
What’s next for you?
Beyond navigating the daily chaos of raising a child while running a company, I’m currently leading preparation for Bened Biomedical’s Initial Public Offering to investors in 2026. This milestone will enable us to invest more deeply in research and innovation to support neurodiverse communities with tailored, science-based solutions.
We also hope to advance neurodiversity destigmatisation in Asia, so that every unique mind can be seen, respected and supported.
Finally, what advice would you give to King’s alumni aiming for careers in neuroscience?
I must admit I don’t have the most comprehensive insight into all neuroscience careers. But from my own corner of the industry, I’d say the future of neuroscience lies not only in data, but in understanding how it transforms lives.
I’d also advise anyone working in the area to stay grounded in science, collaborate across disciplines and never underestimate the power of empathy.
Learn more about Bened Biomedical